We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Invesco Water Resources ETF Trust | NASDAQ:PHO | NASDAQ | Exchange Traded Fund |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.32 | -0.49% | 65.52 | 65.55 | 69.20 | 65.96 | 65.375 | 65.91 | 96,122 | 01:00:00 |
Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations. The slides presented will be available on Photocure's website (www.photocure.com) in the investor relations section.
Company contact:
Erik Dahl, Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.no
About Photocure
Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.
1 Year Invesco Water Resources ... Chart |
1 Month Invesco Water Resources ... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions